Medical Xpress on MSN: Genetic variants in 1 in 10 people may reduce blood‑sugar response to GLP‑1 diabetes drugs More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for people who have certain genetic variants, according to a new ... Genetic variants in 1 in 10 people may reduce blood‑sugar response to GLP‑1 diabetes drugs Hello Health Rounds readers. Today we feature a pair of studies that took a deeper dive into the effects of GLP-1 drugs being widely used for weight loss and diabetes.

Context Explanation

GLP-1 drugs like Ozempic and Wegovy can aid weight loss and diabetes, but come with side effects, high costs and unanswered long-term questions. The American Journal of Managed Care: New Advances in Diabetes Drugs Are Transforming Treatment of Liver Disease Metformin has been used for years to help people with Type 2 Diabetes control their blood sugar. Now, scientists have discovered that the drug also has a significant impact on the brain. ScienceAlert on MSN: After 60 Years, Diabetes Drug Revealed to Unexpectedly Affect The Brain